Transgene S.a annual shares outstanding
2020
2021
2022
2023
2024
2025
Transgene S.a Shares Outstanding History (TNG)
Transgene S.a reported 274.2M shares outstanding at the end of fiscal 2025.
View full Transgene S.a company overviewTransgene S.a annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 274.2M | 141.9M | +107.26% |
| 2024 | 2024-12-31 | 132.3M | 31.4M | +31.18% |
| 2023 | 2023-12-31 | 100.9M | 648,671 | +0.65% |
| 2022 | 2022-12-31 | 100.2M | 2.4M | +2.49% |
| 2021 | 2021-12-31 | 97.8M | 13.9M | +16.61% |
| 2020 | 2020-12-31 | 83.8M | — | — |
Transgene S.a quarterly shares outstanding
Q4.24
Q4.25
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 273.9M | 141.6M | +107.03% |
| Q4 2024 | 2024-12-31 | 132.3M | — | — |
Transgene S.a shares outstanding trends
Over the last five fiscal years, Transgene S.a's shares outstanding moved from 83.8M to 274.2M, a change of 190.3M. The latest reported quarter, Q4 2025, shows 273.9M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
reported period-end shares
TickerStat displays period-end common shares from official filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Transgene S.a source filings ↗